PPARG and neoplasm: Moreover, since PPARγ overexpression plays a potential role in tumour immune escape, simultaneous inhibition of PPARγ and immune checkpoints can reshape the immune landscape of liver tumours, and overcome resistance to immune checkpoint blockers.33